abstract |
The invention discloses a class of lenalidomide/pomalidomide analogs represented by formula (I), which belongs to the technical field of drug synthesis. A class of lenalidomide/pomalidomide analogs disclosed in the present invention can be used for the treatment and/or prevention of multiple myeloma, leukemia and lymphoma, and has a wide range of prevention and treatment for multiple myeloma, leukemia and lymphoma, etc. application prospects. |